Net profit of Entero Healthcare Solutions reported to Rs 20.97 crore in the quarter ended March 2024 as against net loss of Rs 3.72 crore during the previous quarter ended March 2023. Sales rose 16.57% to Rs 1034.18 crore in the quarter ended March 2024 as against Rs 887.21 crore during the previous quarter ended March 2023.For the full year,net profit reported to Rs 39.11 crore in the year ended March 2024 as against net loss of Rs 11.56 crore during the previous year ended March 2023. Sales rose 18.85% to Rs 3922.31 crore in the year ended March 2024 as against Rs 3300.21 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1034.18887.21 17 3922.313300.21 19 OPM %2.792.30 -2.851.94 - PBDT20.708.15 154 60.5720.55 195 PBT13.560.98 1284 35.56-3.69 LP NP20.97-3.72 LP 39.11-11.56 LP Powered by Capital Market - Live News

Entero Healthcare Solutions will hold a meeting of the Board of Directors of the Company on 29 May 2024Powered by Capital Market - Live News

Net profit of Entero Healthcare Solutions rose 104.83% to Rs 6.78 crore in the quarter ended December 2023 as against Rs 3.31 crore during the previous quarter ended December 2022. Sales rose 19.73% to Rs 992.63 crore in the quarter ended December 2023 as against Rs 829.03 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales992.63829.03 20 OPM %2.882.24 - PBDT14.327.92 81 PBT8.322.49 234 NP6.783.31 105 Powered by Capital Market - Live News

Entero Healthcare Solutions will hold a meeting of the Board of Directors of the Company on 8 March 2024.Powered by Capital Market - Live News

The equity shares of Entero Healthcare Solutions (Scrip Code: 544122) are listed effective 16 February 2024 and admitted to dealings on the Exchange in the list of ``B`` Group Securities. Powered by Capital Market - Live News